This study aimed to identify the frequency and heterogeneity of the IKZF1plus profile and mutational spectrum of IKZF1, PAX5, CDKN2A/2B, and ERG in a cohort of 206 Mexican pediatric patients with de novo B-ALL. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.